IRA's inflation-linked rebates would've saved government $3.7B from 2018 to 2020 — JAMA research
A new analysis from Harvard’s Aaron Kesselheim points to the recently signed Inflation Reduction Act as a way that Medicare could’ve saved even more money had it begun earlier.
Published in the Journal of the American Medical Association on Tuesday by Kesselheim and Ben Rome, alongside Alexander Egilman, the analysis pointed out that routine price increases by drugmakers every January are no longer that straightforward thanks to this sweeping law. If the price of a drug increases faster than inflation, drug manufacturers have to reimburse Medicare via rebates starting this year.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
